Oman vs Sri Lanka: Cause of death, by non-communicable diseases, ages 5-14, male
Oman
41.0%
in 2021
Sri Lanka
41.1%
in 2021
Oman rank
72nd
Sri Lanka rank
71st
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Oman
- Sri Lanka
How they compare
Sri Lanka currently reports 41.1% against 41.0% in Oman, a difference of 0.1%.
The two have swapped places 4 times across 6 shared years of data; in 2000 it was Sri Lanka ahead.
Oman ranks 72nd and Sri Lanka ranks 71st of 185 countries.
Across the 3 decades both report, Oman averaged higher in 2 and Sri Lanka in 1.
Head to head by decade
| Decade | Oman | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 37.5% | 39.9% | 2.4% | Sri Lanka |
| 2010s | 39.2% | 37.2% | 2.0% | Oman |
| 2020s | 43.1% | 42.8% | 0.3% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Oman or Sri Lanka?
- Sri Lanka, at 41.1% against 41.0% in Oman as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Oman and Sri Lanka?
- 0.1%, with Sri Lanka ahead.
- How many years of comparable data are there for Oman and Sri Lanka?
- 6 years are reported by both, from 2000 to 2021.
- How do Oman and Sri Lanka rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Oman ranks 72nd and Sri Lanka ranks 71st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.